The Preparedness Roundtable - Infection Control: Candida auris
This event is in the past.
10 a.m. to 11:30 a.m.
Wayne State University's Center for Emerging and Infectious Diseases and the University of Michigan's Public Health Prepared welcomes all members of our community to join us for a special interactive discussion:
Infection Control: Candida auris
Wayne State University's Center for Emerging and Infectious Diseases and the University of Michigan's Public Health Prepared were created in the last year in response to the needs made evident by COVID-19.The Preparedness Roundtable series aims to provide a space for cross-sector education and engagement for those in public health, healthcare, and other related fields in order to build capacity and foster greater collaboration among those working in emergency preparedness.
This four-part quarterly series will focus on a range of issues concerning the role of public health in responding to infectious disease outbreaks and disasters. Topics such as disasters and climate change, public health disparities, and emerging and seasonal disease threats will be covered. The third session will focus on infection control related to Candida auris. This training is centered on State SMEs and Infection Disease Physicians providing education to local public health and healthcare practitioners to equip them with skills needed for future cases.
This training is centered on state SMEs and ID physicians providing education to local public health and healthcare practitioners to equip them with skills needed for future cases.
- Describe what Candida auris is, how it is transmitted, and mitigation strategies
- Characterize the scope of Candida auris infection in Michigan
- Explain the current response to Candida auris at the state level
- Discuss the impact of Candida auris infection on local healthcare systems
- Outline various strategies for passive and active surveillance
- Identify barriers, resources, and opportunities for improved local and statewideresponse (e.g., clinical screening, testing)
Trini Mathew, MD, MPH, FACP, FIDSA, Associate Professor of Medicine at Oakland University, William Beaumont, and Wayne State University; Medical Director of Infection Prevention andAntimicrobial Stewardship at Beaumont/Corewell Health, Taylor, Michigan
Joe Coyle, MPH, MS, Director, Bureau of Infectious Disease Prevention, MDHHS
Seth Eckel, MPH, Viral Hepatitis Unit Manager, MDHHS
Adam Ressler, MD, Preventive Medicine Resident, University of Michigan
Faculty & Planning Committee:
Laura Power, MD, MPH; Dany Zemmel, MPH; Storee Harris-Stubblefield, MPH; Matthew Seeger, PhD; Paul Kilgore, MD, MPH, Natasha Bagdasarian, MD, MPH, FIDSA
Dr. Paul E. Kilgore has disclosures with Moderna, GSK, Janssen, and Pfizer as a researcher. Dr. Trini Mathew has disclosures with Google and GE Healthcare.
All commercial relationships as defined by the ACCME have been mitigated.
The Wayne State University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Wayne State University School of Medicine designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.